FDA NDC Directory · JSON-LD · Markdown

Hetlioz LQ

NDC 43068-304 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Generic nametasimelteon
Labeler / ManufacturerVanda Pharmaceuticals Inc.
Marketing categoryNew Drug Application (innovator) · App NDA214517
Dosage form / routeSUSPENSION · ORAL
Active ingredientsTASIMELTEON (4 mg/mL)
Marketing started20201210
Package count2

External sources

Source: openFDA. Public-domain (CC0).